{
    "id": 32607,
    "fullName": "IGFBP2 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "IGFBP2 over exp indicates an over expression of the Igfbp2 protein and/or mRNA. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3485,
        "geneSymbol": "IGFBP2",
        "terms": [
            "IGFBP2",
            "IBP2",
            "IGF-BP53"
        ]
    },
    "variant": "over exp",
    "createDate": "02/18/2020",
    "updateDate": "02/18/2020",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 20495,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, increased Igfbp2 expression levels were detected at disease progression in patients with melanoma harboring BRAF V600E/K treated with Tafinlar (dabrafenib) and Mekinist (trametinib) combination therapy (PMID: 30143629).",
            "molecularProfile": {
                "id": 35204,
                "profileName": "BRAF V600E/K IGFBP2 over exp"
            },
            "therapy": {
                "id": 1066,
                "therapyName": "Dabrafenib + Trametinib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 17876,
                    "pubMedId": 30143629,
                    "title": "SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/30143629"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 35188,
            "profileName": "IGFBP2 over exp",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 35204,
            "profileName": "BRAF V600E/K IGFBP2 over exp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}